Saudi biotech startup Novo Genomics signed two major agreements: one with Tracer Biotechnologies to localize ctDNA monitoring ...

DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold ...

- 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified ...

The REGENT-1 study assessed the safety and feasibility of the Endogenex Pulsed Electric Field System (the ReCET System) – an investigational, endoscopic outpatient procedure that uses non-thermal ...

The company will present findings on two novel nanomedicine radiotracers: flurimedrimer, which selectively targets activated microglia in the human brain to support its neurology pipeline, and a ...

As we continue to execute, we remain focused on expanding insurance coverage for IB-Stim, which will make this much-needed therapy for abdominal pain associated with IBS and Pediatric Functional ...

Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project ...

Itasca (IL), United States - June 17, 2025. Biocartis Group of Companies (“Biocartis”), an innovative precision oncology company, is pleased to announce the appointment of Ben Svarczkopf, MS, MT (ASCP ...

Lisata to lead development efforts to advance GATC’s AI-discovered therapeutic for opioid use disorder into human clinical trials early in 2026 BASKING RIDGE, N.J. and IRVINE, Calif., June 17, 2025 ...

Arndt Schottelius, MD PhD, CEO, commented: “We are delighted to welcome Stefan to Maxion at this pivotal time in our company's development. His exceptional track record in advancing novel therapeutics ...

Separately, Aptose announced that effective June 16, 2025, Ms. Carol Ashe has resigned as a director of the Company. The Company wishes to thank Ms. Ashe for her valuable contributions during her ...

Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences procurement ...